Երկիր: Իռլանդիա
Լեզու: անգլերեն
Աղբյուրը: HPRA (Health Products Regulatory Authority)
LETROZOLE
Flynn Pharma Ltd
LETROZOLE
2.5 Milligram
Film Coated Tablet
Product subject to prescription which may not be renewed (A)
Withdrawn
2013-08-19
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Letrozole 2.5mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: 2.5 mg letrozole. Also contains Sunset Yellow FCF (E110). For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Film coated tablet Yellow, round, biconvex, film-coated, tablets. Debossed "2.5" on one side, plain on reverse. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS • Adjuvant treatment of postmenopausal women with hormone receptor positive invasive early breast cancer. • Extended adjuvant treatment of hormone-dependent-invasive breast cancer in postmenopausal women who have received prior standard adjuvant tamoxifen therapy for 5 years. • First-line treatment in postmenopausal women with hormone-dependent advanced breast cancer. • Advanced breast cancer in women with natural or artificially induced postmenopausal endocrine status after relapse or disease progression, who have previously been treated with anti-oestrogens.• Neo-adjuvant treatment of postmenopausal women with hormone receptor positive, HER-2 negative breast cancer where chemotherapy is not suitable and immediate surgery not indicated. Efficacy has not been demonstrated in patients with hormone receptor negative breast cancer. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adult and elderly patients The recommended dose of Letrozole 2.5 mg film coated tablets is 2.5 mg once daily. No dose adjustment is required for elderly patients. In patients with advanced or metastatic disease, treatment with Letrozole 2.5 mg film coated tablets should continue until tumour progression is evident. In the adjuvant and extended adjuvant setting, treatment with Letrozole tablets should continue for 5 years or until tumour relapse occurs, whicheve Կարդացեք ամբողջական փաստաթուղթը